INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1783586499 regulatory compliance]( "The Importance Of A Maturity Model For Clinical Trial Transparency")
The Importance Of A Maturity Model For Clinical Trial TransparencyA comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.
-
![Artificial intelligence-macine learning-GettyImages-1368016158]( "How AI Is Reshaping Trial Design, Execution, And Disclosure")
How AI Is Reshaping Trial Design, Execution, And DisclosureAI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
![yes your study is at risk]( "Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints")
Yes, Your Study Is At Risk: Risk Mitigation Plans For EndpointsOcular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
-
![GettyImages-1361096540-patient-family-home-visit]( "Site Networks And Hybrid Solutions")
Site Networks And Hybrid SolutionsLearn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.
-
Why Operational Design Determines Recruitment And Retention4/22/2026
Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.
-
Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution4/6/2026
Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
Why Data Integrity Still Matters — Even As Clinical Trials Evolve12/4/2025
Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.
-
Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy4/11/2025
Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "De-Risk Randomization With The Endpoint Biostatistical Approach")
With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
-
![doctors laptop iStock-1196710776]( "Endocrine & Metabolic Expertise To Enable Your Success")
Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
![Clinicians doctors meeting iStock-1264556832]( "Think Bold. Think Scientific. Think Veristat.")
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
